drugset / Trial / NCT02166268
Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The clinical trial will investigate the efficacy of Avanz Phleum pratense in the treatment of rhinitis in an environmental challenge chamber.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AVANZ Phleum pratense | Unknown | 15000 unknown | Subcutaneous |